Better-for-You Stimulant Formats Gain Scale as Consumer Demand Reshapes Delivery Landscape

Issued on behalf of Doseology Sciences Inc.

VANCOUVER, BC, March 4, 2026 /PRNewswire/ — USANewsGroup.com News Commentary — Consumer habits continue to shift, and there’s no better example to point at than the rise of pouches. The global oral nicotine pouch market is projected to surge from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR^[1]. On top of this, consumer habits are shifting toward tobacco-free formats which are accelerating alongside demand for functional, portable energy delivery systems that eliminate liquid bulk and sugar crashes^[2]. This convergence is channeling capital toward consumer goods platforms built around precise dosing, clean ingredients, and modern form factors, creating scalable opportunities for Doseology Sciences (CSE: MOOD) (OTCPK: DOSEF) (FSE: VU70), Celsius Holdings (NASDAQ: CELH), British American Tobacco (NYSE: BTI), Turning Point Brands (NYSE: TPB), and Keurig Dr Pepper (NASDAQ: KDP).

Another rising star is functional beverages, a market projected to reach $192.8 billion globally in 2026, driven by wellness trends including cognitive support ingredients and stress-relief botanicals^[2]. Energy drinks dominate with 39% market share, benefiting from sustained-release caffeine and natural boosters that appeal to fast-paced consumers seeking alternatives to traditional sugary formats^[3].

Doseology Sciences (CSE: MOOD) (OTCPK: DOSEF) (FSE: VU70) just launched Feed That Brain Energy Pouches in the United States through a direct-to-consumer pilot program, marking the company’s first DTC initiative in the U.S. market. Based in Kelowna, British Columbia, Doseology is testing nicotine-free, caffeine-based oral pouches that deliver clean, controlled energy in a discreet format without sugar, smoke, or liquid consumption. The pouches are now available exclusively to U.S. consumers at feedthatbrain.com and Amazon.com.

The U.S. pilot represents a key milestone in Doseology’s strategy to validate oral pouch delivery as a scalable stimulant platform, beginning with non-nicotine energy products. The company will use this phase to evaluate consumer adoption, usage frequency, and repeat purchase behavior, with particular focus on underserved demographics seeking alternatives to traditional energy drinks.